Skip to content
★ Sign in to follow
OA

Orasolv AB Stock: price and insider trades · Sweden

ISIN SE0001183732SE·

No insider purchase over the last 90 days. The latest, by Håkan Hallberg, was filed 08 Nov 2017.

Orasolv AB: what insiders have been doing

This page follows insider dealings at Orasolv AB as filed with Finansinspektionen. Nothing new has been filed by managers of Orasolv AB in twelve months, the latest record being from 13 April 2018.

Since 2016, the database holds 10 purchases and 4 sales by insiders of the company.

Other companies in the same market with recent insider buying flagged by our signals: Rusta AB (publ) and Karnell Group AB (publ). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Insider Decl.
18
Thresholds
n/a
Buy Volume
€656,688
10 ops. · all time
Sell Volume
€859,541
4 ops. · all time
Last declaration on 13 April 2018
Declarations18 total
  • ▼
    Styrelseledamot/suppleantExecutives
    6M SEK30FI-SE
    21,333,210 shares@ SEK 0.3084.4% of flowISIN SE0010520221FI:csv-4e4bc8b20f74d54c7cf2
  • ▼
    VDExecutives
    216,533 SEK42FI-SE
    746,666 shares@ SEK 0.2983.8% of flowFI:csv-ad7fd2f068bab495d0d6
  • ▼
    FörsäljningschefExecutives
    23,200 SEK10FI-SE
    80,000 shares@ SEK 0.29100.0% of flowISIN SE0004870640FI:csv-00af8931e9df81324154
  • ●
    VDExecutives
    37,333 SEK23FI-SE
    186,666 shares@ SEK 0.2014.7% of flowFI:csv-c5f3130639f2cc737226
  • ●
    Styrelseledamot/suppleantExecutives
    23,333 SEK7FI-SE
    116,666 shares@ SEK 0.200.3% of flowISIN SE0010520221FI:csv-f2dec1b869586c16549d
  • ●
    Styrelseledamot/suppleantExecutives
    180,000 SEK7FI-SE
    900,000 shares@ SEK 0.202.5% of flowISIN SE0010520221FI:csv-3daa3ae3fadf71a8fa43
  • ●
    Styrelseledamot/suppleantExecutives
    863,327 SEK8FI-SE
    4,316,636 shares@ SEK 0.2011.9% of flowISIN SE0010520221FI:csv-260ae9212e2b9ef8ccfc
  • ▲
    Styrelseledamot/suppleantExecutives
    5,250 SEK7FI-SE
    1,749,999 shares@ SEK 0.0030.1% of flowISIN SE0010520205FI:csv-674bfb6791a8662b31af
    Canonical exit: 4 Feb 2018 (T+90)
  • ▲
    VDExecutives
    3,600 SEK34FI-SE
    10,000 shares@ SEK 0.361.5% of flowISIN SE0001183732FI:csv-8c57847df790648fe5ae
    Canonical exit: 1 Aug 2017 (T+90)
  • ▲
    StyrelseordförandeExecutives
    55,500 SEK7FI-SE
    150,000 shares@ SEK 0.370.8% of flowISIN SE0001183732FI:csv-b99065426664e9691494
    Canonical exit: 27 Jul 2017 (T+90)
  • ▲
    FörsäljningschefExecutives
    31,200 SEK10FI-SE
    80,000 shares@ SEK 0.39100.0% of flowISIN SE0001183732FI:csv-1a5debdf430a7646e78f
    Canonical exit: 25 Jun 2017 (T+90)
  • ▲
    Styrelseledamot/suppleantExecutives
    421,855 SEK20FI-SE
    1,105,200 shares@ SEK 0.38177.1% of flowISIN SE0001183732FI:csv-1c1d8fd1b87835695278
    Canonical exit: 25 May 2017 (T+90)
  • ▲
    VDExecutives
    57,000 SEK25FI-SE
    150,000 shares@ SEK 0.3826.8% of flowISIN SE0001183732FI:csv-36e1d4c61bb650621f8e
    Canonical exit: 25 May 2017 (T+90)
  • ▲
    VDExecutives
    160,000 SEK41FI-SE
    400,000 shares@ SEK 0.4073.2% of flowISIN SE0001183732FI:csv-92c15d960e6cf3f17323
    Canonical exit: 19 Mar 2017 (T+90)
  • ▼
    Styrelseledamot/suppleantExecutives
    2M SEK15FI-SE
    5,000,000 shares@ SEK 0.42100.0% of flowISIN SE0001183732FI:csv-59f247cd12374d35f688
  • ▲
    Styrelseledamot/suppleantExecutives
    2M SEK10FI-SE
    5,000,000 shares@ SEK 0.4234.4% of flowISIN SE0004870640FI:csv-74c90ff37cf6635e4cf8
    Canonical exit: 1 Mar 2017 (T+90)
  • ▲
    Styrelseledamot/suppleantExecutives
    385,000 SEK8FI-SE
    1,000,000 shares@ SEK 0.3856.3% of flowFI:csv-13ca952cb8dbee32d95a
    Canonical exit: 14 Feb 2017 (T+90)
  • ▲
    Styrelseledamot/suppleantExecutives
    3M SEK12FI-SE
    8,500,000 shares@ SEK 0.3852.3% of flowFI:csv-58ca9f5f80c8cb5e76be
    Canonical exit: 26 Jan 2017 (T+90)

18 of 18 declarations

About Orasolv AB

Orasolv AB is a company listed on the Stockholm Stock Exchange, specializing in the development of innovative solutions for the pharmaceutical industry. It focuses on enhancing the efficacy of medical treatments.